当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析

沃森生物

(300142)

  

流通市值:155.92亿  总市值:159.93亿
流通股本:15.59亿   总股本:15.99亿

沃森生物(300142)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.51亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1173000.74万元,未分配利润314320.16万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1500370.90万元,负债327370.16万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,141,346,183.011,433,348,556.33599,753,563.654,113,772,327.17
营业总成本1,756,031,473.681,178,655,595.05462,149,769.993,152,213,298.29
营业利润286,082,966.34188,416,703.1859,649,154.49613,966,148.25
利润总额373,789,190.09277,693,243.1557,253,230.61598,976,487.3
净利润350,640,884.9257,516,127.0538,312,226.91511,325,097.99
其他综合收益----
综合收益总额350,640,884.9257,516,127.0538,312,226.91511,325,097.99
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计7,397,846,398.357,492,655,026.818,496,107,457.088,733,170,395.36
非流动资产合计7,605,862,604.547,593,597,678.926,890,774,419.56,855,698,878.04
资产总计15,003,709,002.8915,086,252,705.7315,386,881,876.5815,588,869,273.4
流动负债合计2,389,955,735.472,549,273,542.292,977,682,568.573,203,906,735.46
非流动负债合计883,745,845.96900,096,499.83975,527,059.13989,602,515.97
负债合计3,273,701,581.433,449,370,042.123,953,209,627.74,193,509,251.43
归属于母公司股东权益合计9,589,641,343.389,503,843,180.389,363,403,743.199,349,276,209.07
股东权益合计11,730,007,421.4611,636,882,663.6111,433,672,248.8811,395,360,021.97
负债和股东权益合计15,003,709,002.8915,086,252,705.7315,386,881,876.5815,588,869,273.4
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,578,934,372.581,565,090,966.31631,845,824.415,084,958,951.52
经营活动现金流出小计2,019,529,731.211,474,494,573.76707,439,256.183,951,190,153.79
经营活动产生的现金流量净额559,404,641.3790,596,392.55-75,593,431.771,133,768,797.73
投资活动现金流入小计4,874,532.2247,130-147,521,689.62
投资活动现金流出小计1,177,299,885.811,036,983,127.86162,349,214.98955,515,596.79
投资活动产生的现金流量净额-1,172,425,353.59-1,036,935,997.86-162,349,214.98-807,993,907.17
筹资活动现金流入小计38,399,016.1538,399,016.15183,938.75632,008,709.23
筹资活动现金流出小计156,366,612.13122,451,646.1714,408,241.68395,364,767.13
筹资活动产生的现金流量净额-117,967,595.98-84,052,630.02-14,224,302.93236,643,942.1
汇率变动对现金及现金等价物的影响-5,461,839.45836,946.993,307.832,274,863.67
现金及现金等价物净增加额-736,450,147.65-1,029,555,288.43-252,073,641.85564,693,696.33
期末现金及现金等价物余额3,618,412,563.933,325,307,423.154,102,789,069.734,354,862,711.58
TOP↑